Summit Trail Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
VCM
VPM
Summit Trail Advisors's ELV Position: Q1 2026 in Review
Summit Trail Advisors increased its Elevance Health (ELV) stake by 70% in Q1 2026, buying an estimated $913K and bringing the position to 6,758 shares worth $1.98M. The position accounts for 0.03% of the portfolio, ranked #533.
Summit Trail Advisors first reported a position in ELV in Q4 2017 and has held it in 18 quarters since. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Summit Trail Advisors held 6,758 shares of Elevance Health worth $1.98M as of Q1 2026.
- Summit Trail Advisors bought 2,779 Elevance Health shares in Q1 2026, an estimated $913K.
- Elevance Health made up 0.03% of Summit Trail Advisors's portfolio in Q1 2026, its #533 holding.
- Summit Trail Advisors first reported a position in Elevance Health in Q4 2017 and has held it in 18 quarters since.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Summit Trail Advisors's 13F filing for Q1 2026, filed 12 May 2026.